In an interview with the Journal of the American Medical Association (JAMA), Drs. Rudy Tanzi and Berislav Zlokovic of the Cure Alzheimer's Research Consortium discuss why recent drug trials produced less-than-promising results, and why they are optimistic about the future of the field.
Cure Alzheimer's Fund is excited to share that the 21st Century Cures Act was today signed into law by President Obama. The legislation will substantially increase federal funding for medical research, and aims to improve and accelerate the approval process for new drug treatments.
The bill passed with overwhelming bipartisan support, showing widespread awareness of the need for more research funding and speedier drug development. Outside of government, the legislation was also championed by the drug industry, patient advocates, and academic institutions.
In findings published on The Beacon, Cure Alzheimer’s Fund was selected among 11 charities for The Beacon's 2016 Holiday Gift Guide.
Beacon analysts obtained data from charitynavigator.org, where Cure Alzheimer’s Fund scores a perfect 100 points. As of December 2016, the nonprofit had distributed over $48 million to Alzheimer's research.
In 2013, Sally Rosenfield, senior vice president at Cure Alzheimer's Fund, joined the Women Against Alzheimer’s (WA2) Network Founding Board in Washington, D.C. WA2 is one of the networks established by UsAgainstAlzheimer’s engaged in advocacy and education for the disease.
(CHICAGO, IL) – OCTOBER 7, 2016 – Rotary and Cure Alzheimer’s Fund today announced an agreement to co-fund a new, groundbreaking research project to search for female-specific genetic and other factors contributing to women’s risk for Alzheimer’s disease. In total, the two organizations will provide a grant of $375,000 for this critical research.
In 2003, Bob DeMarco realized there was something “dramatically wrong with his mom, Dotty.” He later learned she was living with Alzheimer’s disease. He left his position as a Wall Street executive and CEO of a software company to care for her. Bob soon found a place he calls “Alzheimer’s World,” where caregivers and their loved ones become bonded by “emotional super glue.”
What do the developing brain and the Alzheimer’s brain have in common? Beth Stevens, Ph.D., a developmental neurologist, is investigating an important connection: the loss of synapses, where neurons connect with one another to transmit important signals.